assess-target-drug-bd-opportunities-ls

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

• Third-party content exposure detected (low risk: 0.10). The required workflow only retrieves third-party evidence via pre-verified, user-scoped Patsnap MCP tools (target_disease, drug_asset, clinical_trials, patent search/briefing, scientific_translational_evidence, regulatory_guidelines, current_awareness) and does not describe any ingestion of arbitrary outsider-authored free text pushed into an external feed/queue that the workflow monitors without selecting specific items.